Feasibility Study for Fibroblast Autologous Skin Grafts

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT01964859
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Wounds and Injuries

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • autologous skin fibroblasts — BIOLOGICAL
    autologous skin fibroblasts
  • Filler Product — BIOLOGICAL
    In some select subjects the investigators will test if the addition of an FDA approved filler product Bellafill might enhance cellular efficacy.

Study Details

This research is being done to determine if investigators can change skin from one type to another. Specifically, investigators are interested in making normal skin into the thicker skin found on our palms and soles.

Key Dates

Start date
Jan 7, 2015
Status verified
Jun 2026
Primary completion
Dec 2, 2027
Completion
Nov 1, 2028

Study Design

Enrollment
80 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: autologous skin fibroblasts
    The investigators are comparing 3 injection sites in the same individual

Primary Outcome Measure

Cytoplasmic size increase [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins School of Medicine, Dermatology DepartmentBaltimoreMaryland21287
Sherry Leung
[email protected]
410-502-7546
Luis Garza, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

By research site
Johns Hopkins School of Medicine, Dermatology Department· Baltimore, MD

Related Studies